Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “joint appointments”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

16 records
All sourcesNASA NTRSDOE OSTI
DOE OSTI2020

Joint Appointments: General Principles for Joint Appointments between LANL and University Partners

The Joint Appointment Program provides opportunities for LANL and partner universities to recruit, retain, and recognize premier scientists and engineers by offering them the ability to work in both the LANL and university environments. These interactions enhance the ability of both institutions to achieve their respective research and development missions while providing increased academic strength to educational institutions.

96 KNOWLEDGE MANAGEMENT AND PRESERVATION↗
DOE OSTI2016

Virtual Special Issue on Catalysis at the U.S. Department of Energy’s National Laboratories

Catalysis research at the U.S. Department of Energy's (DOE's) National Laboratories covers a wide range of research topics in heterogeneous catalysis, homogeneous/molecular catalysis, biocatalysis, electrocatalysis, and surface science. Since much of the work at National Laboratories is funded by DOE, the research is largely focused on addressing DOE's mission to ensure America's security and prosperity by addressing its energy, environmental, and nuclear challenges through transformative science and technology solutions. The catalysis research carried out at the DOE National Laboratories ranges from very fundamental catalysis science, funded by DOE's Office of Basic Energy Sciences (BES), to applied research and development (R&D) in areas such as biomass conversion to fuels and chemicals, fuel cells, and vehicle emission control with primary funding from DOE's Office of Energy Efficiency and Renewable Energy.

09 BIOMASS FUELS↗
DOE OSTI2016

Report in the Energy and Intensity Frontiers, and Theoretical at Northwestern University

The Northwestern (NU) Particle Physics (PP) group involved in this report is active on all the following priority areas: Energy and Intensity Frontiers. The group is lead by 2 full profs. in experimental physics (Schmitt and Velasco), 3 full profs. in theoretical physics (de Gouvea, Low and Petriello), and Heidi Schellman who is now at Oregon State. Low and Petriello hold joint appointments with the HEP Division at Argonne National Laboratory. The theoretical PP research focuses on different aspects of PP phenomenology. de Gouvea dedicates a large fraction of his research efforts to understanding the origin of neutrino masses, neutrino properties and uncovering other new phenomena, and investigating connections between neutrino physics and other aspects of PP. Low works on Higgs physics as well as new theories beyond the Standard Model. Petriello pursues a research program in precision QCD and its associated collider phenomenology. The main goal of this effort is to improve the Standard Model predictions for important LHC observables in order to enable discoveries of new physics. In recent years, the emphasis on experimental PP at NU has been in collider physics. NU expands its efforts in new directions in both the Intensity and the Cosmic Frontiers (not discussed in this report). In the Intensity Frontier, Schmitt has started a new effort on Mu2e. He was accepted as a collaborator in April 2015 and is identified with important projects. In the Energy Frontier, Hahn, Schmitt and Velasco continue to have a significant impact and expanded their CMS program to include R&D for the real-time L1 tracking trigger and the high granularity calorimeter needed for the high-luminosity LHC. Hahn is supported by an independent DOE Career Award and his work will not be discussed in this document. The NU analysis effort includes searches for rare and forbidden decays of the Higgs bosons, Z boson, top quark, dark matter and other physics beyond the standard model topics. Four students completed their PhD: Kubik is now contributing to the Cosmic Frontier program, Pollack to both the Intensity and Energy Frontiers and Pozdnyakov and Odell will continue in the Energy Frontier. All our research scientists, Anastassov, Oferzynski, Lusito, and Stoynev, have found new positions. The new post-docs are Trovato from Scuola Normale de Pisa, Odell from Northwestern and Bhattacharya from Brown. Trovato is now supported by Hahn, and so is Sung, previously at MIT.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗
DOE OSTI2023

Human Dimensions of Energy Systems Workshop - September 6-7, 2022: Findings and Next Steps

Advanced energy technologies and informed policies are necessary but not sufficient to accelerate the energy transition at the speed required to meet our shared climate and energy resilience goals. To fully understand and implement integrated energy systems, we need to be able to model and analyze the complete system-of-systems, including the behavior of people interacting with and being impacted by energy systems. The purpose of this workshop is: Understand how human behavior and decisions affect the performance of energy systems with a focus on resilience and human well-being; Identify opportunities to improve energy system design to explicitly consider human behavior and well-being; Enhance our capability to model and predict human actions. Develop the ability to stress test these integrated systems; Identify or develop requirements and tools for more robust system designs that can be used for human-in-the-loop exercises and training; Identify opportunities for joint research, joint appointments, and collaboration; and Guide internal investments and strategic hires.

analyze↗
DOE OSTI2014

TU-A-17A-01: Memorial to Benjamin M. Galkin - Memorial Lecture

This past year Medical Physics lost one of its active members, Benjamin M. Galkin. Ben Galkin was a Past-Treasurer of the AAPM. During his leadership role he played an important part in Securing membership, for the AAPM, in the American Institute of physics. As Treasurer he was also a prime mover in starting the journal, Medical Physics, and served as its business manager in the formative years.Ben Galkin received his Masters Degree at Columbia University in New York, under the mentorship of Dr. Edith Quimby, one of the pioneer Hospital Radiation Physicists in the country. He started his professional career at Jefferson Hospital in Philadelphia, joining Robert Gorson, and remained there until retirement. He served as the institution’s Radiation Safety Officer throughout his career. His research interest was Breast Imaging. He held joint faculty appointments in the Department of Radiology and the Department of Radiation Therapy and Nuclear Medicine, rising up to the rank of Full professor. He was a well respected teacher for the residents in Radiology.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

Strategy of the Joint Center for Energy Storage Research to Influence Laboratory Safety Among its Funded Researchers

In 2011, a team at Argonne National Laboratory (Argonne) was preparing a proposal for a Department of Energy (DOE)-funded project that called for the creation of an “Energy Innovation Hub.” The proposal team, well engrained in Argonne's and DOE's safety culture, was also aware of the high profile university laboratory accidents from 2009 and 2010 and many other high profile research laboratory safety incidents. They knew they wanted to influence safety by setting an expectation of safe science across the Hub they proposed. In 2012, the DOE awarded Argonne the contract to create the Hub, now known as the Joint Center for Energy Research (JCESR). JCESR promptly hired and appointed a Safety Lead charged with fulfilling JCESR's vision of influencing safety across their newly created Hub. This article discusses JCESR's implementation of a strategy to influence laboratory safety among its funded researchers.

Influencing Safety↗
DOE OSTI2022

Operation Dominic

A very tall (6’5”) Austin McGuire endured duty aboard the cramped confines of a submarine during World War II. After receiving a doctorate in physics from the University Rochester, he came to Los Alamos in 1954, later participating in the Koa shot of Operation Hardtack I. In 1962, he was appointed Deputy Commander of the Los Alamos task unit of Joint Task Force 8 (8.1.1) and sent to Christmas Island for Operation Dominic.

45 MILITARY TECHNOLOGY, WEAPONRY, AND NATIONAL DEF↗
DOE OSTI2018

Evaluating the Pharmacodynamics and Protective Efficacy of Catalytic Bioscavenger following Subcutaneous Administration in Guinea Pigs

Previous studies determined the guinea pig was a viableanimal model for evaluating subcutaneous ( s.c. )injection as an alternative route of administration of catalytic Bioscavengers:enzymes designed to render nerve agents non‐toxic in systemic circulation following exposure. Recent studies have focused on evaluating the pharmacodynamics (PD) and protective efficacy (PE) of the lead bioscavenger candidate, organophosphorus hydrolase (OPH) variant, YT, as both unmodified and modified (PEGylated) versions of the enzyme. A comparative study was conducted with YT and three progressively sized PEG‐YT variants (934, 935, and 936) following a single bolus s.c. dose (5 mg/kg). Bioavailability increased linearly with molecular size such that the largest sized PEG‐YT variant, 936, afforded the highest bioavailability, thus promoting 936 to subsequent PD and PEstudies. Dose dependence on bioavailability was also examined via three cohorts of guinea pigs receiving doses (5, 15, 20 mg/kg) of either YT or 936 in which a linear dose response was also found. Guinea pigs receiving either YT or 936 (5 mg/kg) via intramuscular (i.m. )or s.c. routes had superimposable PD profiles regardless of route, suggesting an identical absorption pathway for the drugs. Protective efficacy was also evaluated by exposing the animals to 2xLD 50 of sarin (GB) 7 dayspost‐enzyme administration; only the animals receiving 936 ( i.m. and s.c. ) survived 24 hours post‐exposure. Periodic s.c. dosing strategies were also evaluated with 936 in which three injections were administered either 2 or 24 hours apart for a total dose of 15 mg/kg followed by a protective efficacy assessment 8 days post‐administration. Overall these data support the use of s.c . injection as a practical route of administration for catalytic bioscavenger with PE Gylation, synergistically enhancing both bioavailability and extending drug half‐life in circulation. Support or Funding Information The views expressed in this abstract are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government. The experimental protocol was approved by the Animal Care and Use Committee at the United States Army Medical Research Institute of ChemicalDefense and all procedures were conducted in accordance with the principlesstated in the Guide for the Care and Use of Laboratory Animals and the AnimalWelfare Act of 1966 (P.L. 89–544), as amended. This work was supported by the Defense Threat Reduction Agency‐Joint Science and Technology Office, MedicalS&T Division. *Thisresearch was supported in part by an appointment to the Postgraduate ResearchParticipation Program at the U.S. Army Medical Research Institute of ChemicalDefense administered by the Oak Ridge Institute for Science and Educationthrough an interagency agreement between the U.S. Department of Energy and USAMRMC. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Dao, Thuy↗
DOE OSTI2018

Quantitative Method Development and Validation of Naloxone and 6α‐naloxol from Male African Green Monkey Plasma.

Theopioid epidemic is a rapidly growing crisis around the world. Current models forpharmacokinetic assessment of countermeasures use African green monkeys (AGM). Arapid, sensitive and selective method was developed and validated usingLC‐MS/MS for the determination of naloxone and 6α‐naloxol in AGM plasma. Samplepreparation involved a simple solid phase extraction (SPE) using ahydrophilic‐lipophilic‐balanced reversed‐phase cartridge. Separation of naloxoneand 6α‐naloxol was achieved on a Halo C18, 2.1 × 50 mm, 2.7μ analytical columnusing an Agilent 1290 Infinity HPLC. A solvent system of methanol‐water‐formicacid was used for the elution of analytes. The analytes were detected and monitoredby a SCIEX QTRAP 6500 + triple quadrupole tandem mass spectrometer operatedin electrospray ionization (ESI) positive mode and multiple reaction monitoring(MRM). Molecular ion transitions for naloxone, 6α‐naloxol and naloxone‐D5 were 328.0/212.0,330.0/185.0, and 333.1/212.0 m/z, respectively. The method was validated usingcalibration and recovery assays with spiked samples. Linear calibration curveswere generated over the range of 1.5–100 ng/ml with values for the coefficientof determination (R 2 ) of >0.9950. The values for both inter‐dayand intra‐day precision and accuracy were well within the generally acceptedcriteria for analytical methods (≤15%). This method was subsequentlyused to measure plasma concentrations of naloxone and 6α‐naloxol in male AGMs administerednaloxone subcutaneously and intravenously. The developed method demonstratedexcellent recovery, repeatability, accuracy and sensitivity. Support or Funding Information DISCLAIMERS. The views expressed in this abstractare those of the authors (s) and do not reflect the official policy of theDepartment of Army, Department of Defense, or U. S. Government. This researchwas supported by the Defense Threat Reduction Agency – Joint Science andTechnology office, Medical S&T Division. Thisproject was supported in part by an appointment to the Research ParticipationProgram for the U.S. Army Medical Research and Materiel Command administratedby the Oak Ridge Institute for Science and Education through an agreementbetween the U.S. Army Medical Research and Materiel Command. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Bandaru, Veera Venkata Ratnam↗
DOE OSTI2018

Organophosphate Hydrolase (OPH) Designed as a Functional Monomer

Organophosphate hydrolase (OPH) mutants haveshown potential use as a medical countermeasure against a range of differentorganophosphorus compounds (OPs). OPH is typicallyexpressed in bacteria as a homodimer. Two separate monomers (~37kDa each) self‐assemble throughnon‐covalent bonding at the enzyme face close to the putative active site, andenzyme activity is dependent upon dimer formation. OPH homodimers do notsecrete expediently from mammalian cells and are often misfolded. This causespotential problems when trying to express the protein from a heterologous plasmidor viral delivery system. To enhance secretion of OPH from mammalian cells, wesought to increase protein solubility without catastrophic detriment toactivity and without addition of fusion proteins. To this end, we designed OPH tobe expressed as a functional monomer by joining two OPH subunits with a poly‐glycinelinker and expressing it as a single polypeptide in bacteria to evaluateactivity. We created the single polypeptide OPH with a tether 10 or 35 aminoacids in length between the two halves, and named them T10 and T35, respectively. Western blot analysis and paraoxon hydrolysis assays revealedthat T10 was being produced and there was a 71% loss in specific activity comparedto an untethered homodimer positive control. This was a surprise as we expectedT10 to have no enzymatic activity since the tether was too short to allowproper dimer formation. The T35 functional monomer (~76 kDa) was produced showing 29% loss of specific activity. Both T10 and T35 OPH showed high molecular weight aggregate formation greater than 250 kDa in dynamic light scattering and native polyacrylamide gels. Construction of a functional OPH monomer with activity against OPs is instrumental in designing secretable OPHs for adeno‐associatedviral expression. It may also prove useful in the development of chimeric OPHs for maintaining control over the composition of each OPH half, allowing blended activities against a combination of organophosphorus substrates. This is the first attempt known for producing OPH as a functional monomer. Support or Funding Information The views expressed in this abstract are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government. This research was supported by the Defense Threat Reduction Agency – Joint Science and Technology Office, Medical S&T Division. This research was supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Medical Research Institute of Chemical Defense administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRMC. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Baker, Cetara↗
DOE OSTI2016

After Action Report - CUP-2 Comparative Sample Analysis Meeting - Kazakhstan September 2016

Representatives from the U.S. Department of Energy’s Office of Nuclear Smuggling Detection and Deterrence (NSDD) visited the Kazakhstan Institute of Nuclear Physics (INP) to discuss the results and conclusions of a joint sample analysis (CUP-2 uranium ore concentrate) between LLNL, INP and the Japan Atomic Energy Agency (JAEA) (Fig. 1). The U.S. delegation also met with the newly-appointed Director-General of the INP (S. Sakhiyev) who expressed his continued support for this collaboration. On the last day of the visit, the delegation toured the new medical isotope production facilities (which is expected to begin operation in a few months), as well as INP’s Nuclear Security Training Center (co-funded by DOE, the Defense Threat Reduction Initiative (DTRA) and the Kazakhstan government). Construction of the Nuclear Security Training Center is expected to be completed by the end of 2016.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗
DOE OSTI2019

Optimization of an in Vitro CYP450 Induction Assay Using Cryopreserved Cell Lines

Cytochrome P450 (CYP450) enzymes are responsible for the majority for Phase I metabolism. Induction occurs when a drug increases the rate of CYP450 enzyme production. As a result, the rates of metabolism of subsequent drugs increase, posing concerns for dosing and safety. To further expand the USAMRICD Absorption, Distribution, Metabolism, Excretion, and Toxicity Center of Excellence (ADMET CoE) profiling capabilities, a CYP450 induction assay is being developed using alternative cell lines to primary human hepatocytes to measure changes in gene expression of CYP1A2 and CYP3A4 isoenzymes. Primary human hepatocytes are the gold standard for evaluating P450 induction in vitro ; however, they have inherent limitations such as high costs, fastidious nature, and significant lot‐to‐lot variability. Induction assessments using cryopreserved hepatocytes and two immortalized cell lines, HepaRG and HepatoCells, are being conducted to determine a more robust, cost‐effective alternative model. Each cell line was exposed to the standard inducers rifampicin and omeprazole to assess CYP3A4 and CYP1A2 activity, respectively. Following a 72‐hour incubation period, RNA from the cell cultures was extracted and purified. Fold changes of gene expression were measured using real‐time quantitative PCR (RT‐qPCR). Hepatocytes displayed an average fold change of 92.7 for CYP3A4 and 49.6 for CYP1A2, whereas HepaRG displayed changes of 28.6 and 179.5, respectively. Average values for CYP3A4 and CYP1A2 for HepatoCells were 58.7 and 43.9. Based on the data, HepatoCells most closely mimicked cryopreserved hepatocytes in comparison to HepaRG cells. Additional data on assay parameters and technique optimization will be presented. Support or Funding Information Opinion disclaimer: The views expressed in this abstract are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense, or the U.S. Government. This project was generously supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Medical Research Institute of Chemical Defense administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and U.S. Army Medical Research and Materiel Command. Support is also provided by the Defense Threat Reduction Agency – Joint Science and Technology Office, Medical S&T Division. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Lim, Tae Young↗